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Background In 2004, the United Nations Children’s Fund (UNICEF) 
and the World Health Organization (WHO) revised their recommen-
dations for management of acute diarrhea in children to include zinc 
treatment as well as oral rehydration solution (ORS). Little is known 
about how caregivers in low–resource settings perceive and use zinc 
treatment.
Methods Using a semi–structured quantitative survey, we inter-
viewed Kenyan caregivers who had used zinc to treat children aged 
6–60 months with an episode of diarrhea during the previous 6 
months. The survey asked about experience using zinc, compliance 
with course and dosing regimens, and the attributes of zinc com-
pared with other treatments. We surveyed a quota sample of 100 
women from several communities where zinc treatment was avail-
able, primarily through public sector providers.
Results The mean duration of the reference diarrhea episode was 
5.3 days (95% confidence interval (CI) 4.7–5.9). Eighty–two respon-
dents had used zinc tablets, and 18 had given zinc syrup. Among 
those who used tablets, 62% reported giving zinc for fewer than the 
recommended 10 days, with a mean of 6.8 days (95% CI 6.1–7.4 
days), and 50% said they had been instructed to give zinc for 5 days 
or less. Also, only 55% gave the correct daily dose. When asked 
about other treatments, 64% of the respondents reported using an-
tibiotics, 59% ORS, and 56% a homemade remedy. Among the zinc 
tablet users, 55% provided zinc as the 3rd or 4th treatment for the ref-
erence episode. Also, 75% of respondents reported receiving the zinc 
treatment free of charge. Caregivers reported a very high level of sat-
isfaction with zinc treatment, with 88% indicating that zinc (either 
in tablet or syrup form) was their most preferred treatment.
Conclusions Despite the potential benefits of zinc for children with 
acute diarrhea in low–resource settings, treatment regimens remain 
unwieldy and unrealistic, perhaps unnecessarily. Furthermore, the 
availability of zinc is limited primarily to public–sector providers. 
Increasing access to this treatment beyond the public clinic or hos-
pital may accelerate uptake and sustained use.
Globally, diarrhea remains one of the most significant causes of under–five 
mortality. It leads to an estimated 800 000 deaths annually in this age 
group, predominantly in developing countries [1]. In 2004, the World 
Health Organization (WHO) revised its recommendations for the man-
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agement of acute diarrhea to include zinc treatment in con-
junction with the administration of oral rehydration solu-
tion (ORS). Specifically, these guidelines recommend 20 
mg of zinc per day at the onset of illness for 10 to 14 days 
(10 mg for infants under 6 months of age) [2]. These rec-
ommendations are based on evidence indicating that zinc 
can reduce the duration and severity of diarrhea and help 
to prevent recurrence for up to2 to 3 months [3]. In addi-
tion, some studies suggest that the promotion and use of 
zinc as a diarrhea treatment can reduce the inappropriate 
use of antibiotics [4].
Previous studies have indicated that caregivers sometimes 
use more than one intervention for treating diarrhea, and 
zinc has joined a number of interventions available to care-
givers [5]. As with other interventions, zinc is not always 
used in isolation or just with ORS. Instead, it may be used 
in conjunction with one or more additional interventions. 
Some of these interventions, such as antibiotics and anti-
motility drugs, are not recommended for use in children 
in most cases. Others, such as home remedies, are valid 
components of oral rehydration therapy.
Because of the relatively recent addition of zinc to the port-
folio of products for treating diarrhea in children, and the 
slow pace of uptake, there is limited information outside 
of controlled research settings on the behaviors of caregiv-
ers who have provided zinc to children, their ability to fol-
low the therapy regimen, and their treatment preferences. 
Information from caregivers about how well zinc performs 
relative to other products, and their perceptions of the 
competing products, would be useful in developing pro-
grams aimed at increasing zinc use.
This article reports several key findings from a recent sur-
vey of caregivers in a rural area of Kenya about their behav-
iors and experience with using zinc to treat diarrhea in 
young children, their treatment and dosing practices, and 
views on how zinc compares with other interventions.
METHOdS
Participants
We surveyed a quota sample of 100 caregivers in Kenya’s 
Bungoma district. Interviewers visited households and ad-
ministered a recruitment questionnaire to determine if they 
met the criteria for inclusion in the study. Key inclusion 
criteria included recent experience of diarrhea (within last 
six months), awareness of zinc and use of zinc in treating 
diarrhea in a child between 6 and 60 months old. We used 
a semi–structured oral survey with both open–ended and 
close–ended questions and interviewed caregivers in their 
homes. Because of the low coverage of zinc treatment in 
Kenya (as in most countries), survey participants were re-
cruited from households with children in communities in 
Bungoma where this treatment was generally available 
through public or private health providers, clinics, and 
hospitals.
Participants were recruited in several villages (Sangalo, Ku-
lisiru, Naitiri, Bungoma town, Kituni) within Bungoma dis-
trict in Kenya’s Western Province, a predominantly agricul-
tural area. In these communities, blister packs of ten 20 mg 
tablets were generally available through public–sector clin-
ics and hospitals as part of a pilot effort to introduce zinc 
for the treatment of diarrhea. Providers in these areas had 
received some training about new guidelines for diarrhea 
management that include use of zinc. In addition, a mod-
est radio campaign in these areas had included information 
on both prevention of diarrhea (hand washing, sanitation, 
etc.) and treatment using ORS and zinc. Both the training 
and the media campaign had concluded approximately 18 
months before the survey was conducted.
Survey
An original survey was created for the purpose of this study. 
An initial draft was pilot tested for appropriateness and ef-
fectiveness, and to determine the usefulness and complete-
ness of the responses. Based on the results of the pilot test 
the survey instrument was finalized. The implementation 
of the survey took approximately one hour to complete 
with most of the mothers.
The survey asked specifically about the most recent case of 
diarrhea in which zinc was administered. Survey questions 
elicited information pertaining to treatment practices, care-
givers’ overall satisfaction with use of zinc, comparisons 
with other products used, and understanding of the appro-
priate dosing regimen. To assist with recall and to overcome 
a respondent’s potential inability to identify brand names 
of medicines or classifications, several areas of questioning 
relied on the use of pictures of locally available products 
(antibiotics, ORS, etc.). In all cases, the surveys were given 
in local languages.
Data analysis and presentation
In the case of the categorical questions, frequencies have 
been reported. In the case of numeric questions, the full 
distributions of results, including mean, as well as median 
have been reported. Median has been reported where rel-
evant in consideration of the sample and type of questions 
being analyzed. As the survey was designed to provide a 
snapshot of attitudes and behaviors within a relatively small 
sample, the emphasis was on identifying the typical pat-
terns that emerge. Based on this, the median provides a 
good measure of typical behaviors in terms of actual num-
ber of days of episode or number of tablets given as op-
posed to the mean which provides the statistical average 
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but does not necessarily represent a typical behaviour.
The data were entered into computer and then analyzed 
using SPSS. Throughout the study, the market research 
agency (IPSOS Healthcare) maintained its standing permis-
sions from the relevant authority in Kenya to conduct mar-
ket and social research such as this study. IPSOS also ad-
heres to the ICC/ESOMAR Code on the ethical conduct of 
market and social research [6]. This study was determined 
to be non–research by PATH’s Research Ethics Committee. 
Individuals’ participation in the surveys was entirely vol-
untary and anonymous, and all data was aggregated.
RESULTS
Respondent demographics
All surveyed caregivers were women who had used zinc to 
treat diarrhea in a child between 6 and 60 months within 
the past 6 months. Table 1 summarizes the demographics 
of the participants. Approximately two–thirds were less 
than 30 years old. More than a half were working full or 
part time. Most came from the two lowest income groups, 
which is consistent with the rural, low–income status of 
the region.
Duration of illness and treatments used
The mean duration of illness for which the caretaker pro-
vided zinc was 5.3 days (95% confidence interval (CI) 4.7–
5.9), with approximately one–third of the cases lasting 6 
days or more (Table 2). Ninety caregivers reported using 
at least two treatments, and 30 reported using at least four 
treatments in the reference episode (Table 3). Sixty–four 
reported using antibiotics for the same bout of illness, 59 
used ORS sachets, and 56 used a home remedy. Forty–nine 
gave a home remedy as their first treatment. Among the 82 
who administered zinc tablets, 19% administered the prod-
uct as the 3rd treatment and 26% as the 4th treatment.
Therapy regimen and dosing
The respondents were asked a series of questions about the 
zinc therapy and dosage regimen they had followed. Out 
of 82 zinc tablet users, 62% indicated that they had admin-
istered zinc for fewer than the recommended 10 days 
(mean = 6.8 days), 35% reported giving zinc for 10 days, 
and 2% administered zinc for 11 or 12 days (Figure 1). 
Among those who had given zinc for fewer than 10 days, 
Table 1. Percentage distribution of respondents by demographic 
characteristics
Characteristic % of respon-
dents (n = 100)
Age:
18–24 y 37
25–29 25
30–34 16
35 or more 22
Employment status:
Not working 41
Working full time 22
Working part time 29
Unemployed, looking for work 8
Socio–economic grade:*
C1 – Supervisory, clerical and junior 
managerial, administrative or professional 13
C2 – Skilled manual workers 42
D – Semi and unskilled manual workers 45
*In Kenya, the socio–economic grades as initially defined by the 
British National Readership Survey (and often used in market re-
search globally) were used with adapted criteria in common use 
among members of the Marketing and Social Research Associa-
tion of Kenya [7].
Table 2. Duration of reference diarrhea episode (zinc was 
typically started on day 3)
No. of days % of respondents (n = 100)
1 5
2 5
3 11
4 25
5 20
6–10 28
More than 10 6
Median 5
Mean 5.3 (95% CI 4.7–5.9)
CI – confidence interval
Table 3. Number and sequence of treatments used in the reference episode of diarrhea (n = 100 respondents)*
Treatment type All treatments in 
reference episode†
First treatment  
used
Second treatment 
used
Third treatment 
used
Fourth treatment 
used
Homemade remedy 56 49 4 – 1
Powdered ORS 59 13 26 8 –
Zinc tablets 82 7 29 19 26
Zinc syrup 18 5 7 4 2
Antibiotics 64 26 20 16 1
Antimotility 13 – 4 6 –
*Questions: When your child had this diarrhea episode, did you give anything shown on this illustration apart from anything you have 
already mentioned in relation to foods or diet? What did you use first? What did you use second? Third? Fourth?
†Some respondents indicated using more than four treatments. As a result, the sum of four treatments used may not total all treatments 
used.
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Figure 1. Duration of zinc therapy in days (n = 82 respondents).
4 in 10 reported that they had received instructions to ad-
minister zinc for 10 days but did not do so, and approxi-
mately 5 in 10 reported they had been instructed to provide 
zinc for 5 days or less.
Among the zinc tablet users, 13% reported giving less than 
the recommended daily dose (20 mg per day), 55% gave 
the correct daily dose, and 32% gave more than the recom-
mended dose (Figure 2). Typically, those who under–
dosed gave half a tablet per day and those who over–dosed 
gave one tablet twice per day.
Source and cost
Among those who used zinc tablets, 92% reported access-
ing the product through a public source, either a govern-
ment hospital (60%) or a government health center/clinic 
(32%) (Table 4). About 6% reported receiving the product 
from a private clinic or provider. In all instances, the num-
ber of tablets provided was 10, which is the total number 
of tablets in a blister pack typically available in Kenya. 
Among 18 respondents who used zinc syrup, most re-
ceived the syrup from a public source. Only 9% of tablet 
users and 17% of syrup users reported paying for the prod-
uct. Also, 75 respondents reported receiving ORS when 
they received the zinc.
Zinc treatment experience
Ninety–one women indicated that the zinc caused no neg-
ative effects on the child. Four, however, reported nausea, 
3 reported dizziness, and 2 could not recall whether there 
were side effects. Despite minor, negative side effects in a 
few children, all 100 respondents said they would use zinc 
again the next time their child had diarrhea.
Perceptions of zinc attributes
Most respondents had previously used other diarrhea treat-
ments, with the most common being antibiotics, ORS, and 
home remedies (Table 5). Seventy respondents indicated 
that zinc tablets were their most preferred product, and 18 
expressed a preference for zinc syrups. Although 91 re-
spondents were aware of antibiotics and 82 had previous-
ly used them, only 5 indicated that antibiotics were their 
most preferred treatment.
Respondents who preferred zinc tablets over other products 
gave a number of reasons for this preference. About 74% 
reported that it “stopped the diarrhea,” 60% said it “worked 
faster,” and 40% said it “restores energy” (Table 6).
When asked what they believed zinc would do for their 
child based on their experience, 82% of caregivers first 
mentioned “stop the diarrhea” (Table 7). Attributes typi-
cally mentioned second were “improve the appearance of 
stools” (20%), “Help treat the diarrhea faster, so diarrhea 
did not last as long” (18%), and“ reduce the frequency of 
bowel movements” (17%). Other commonly noted expec-
tations included “improve child’s energy level”, “improve 
the child’s appetite”, and “give protection against future 
episodes of diarrhea.”
Discussion
In 2004, UNICEF and WHO introduced new guidelines 
for the management of acute diarrhea in children. The 
guidelines recommended use of zinc along with ORS be-
cause of the results of numerous clinical trials demonstrat-
ing that zinc treatment helps to reduce the duration and 
severity of illness and prevent early recurrence [2,3]. Zinc 
and ORS are not isolated in the marketplace, however. 
Caregivers and consumers have access to a range of prod-
ucts for treating diarrhea in children. Some are appropriate, 
and some are not. In addition, caregivers often use more 
than one product or intervention during a diarrheal epi-
sode. What has been poorly understood is how caregivers 
perceive zinc relative to other available interventions in ar- Figure 2. Daily dosage of zinc tablets (n = 82 respondents).
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Table 4. Source of zinc and median number of tablets provided
Source % of respondents 
using zinc tablets 
(n = 82)
Median number of 
zinc tablets provided
Mean number of zinc 
tablets provided  
(95% CI)
% of respondents 
using zinc syrup 
(n = 18)
Government health center or clinic 32 10 7.98 (7.01–8.93) 22
Government hospital 60 10 8.3 (7.56–9.04) 61
Private pharmacy 1 10 10 6
Private clinic 5 10 10 6
Other 2 n/a 6
CI – confidence interval
Table 5. Caregivers’ awareness of and experience with various diarrhea treatments and their most preferred treatment (n = 100 
respondents)
Treatment Aware of the treatment (%) Ever used the treatment (%) Most preferred treatment (%)
Antibiotics 91 82 5
ORS 85 77 6
Zinc tablets 83 82 70
Home remedy 95 61 0
Antimotility drugs 49 19 1
Zinc syrups 28 22 18
ORS – oral rehydration solution
Table 6. Reasons for preferring zinc over other products
Reason cited for preferring zinc % respondents preferring zinc tablets (n = 70) % respondents preferring zinc syrups (n = 18)
Effective – it stops diarrhea 74 61
It works faster 60 50
Restores energy 40 39
It helps the child gain appetite 20 17
Easily prepared/administered 13 11
It’s cheap 6 6
Recommended by doctors 6 11
It’s free of charge 6 11
Table 7. Caregivers’ expectations for zinc treatment based on experience (n = 100 respondents)
Expectation about what zinc would do for child 1st choice 
(%)
2nd choice 
(%)
3rd choice 
(%)
4th choice 
(%)
5th choice 
(%)
Stop the diarrhea 82 9 1 1 0
Reduce frequency of bowel movements 9 17 7 1 0
Help treat the diarrhea faster, so diarrhea did not last as long 5 18 8 2 0
Improve appearance of stools 2 20 5 1 0
Improve child’s energy level 0 8 10 3 1
Improve child’s appetite 0 10 13 4 1
Improve child’s health 0 3 5 6 2
Improve look of child’s eyes 0 1 1 – 1
Give protection against future episodes of diarrhea 0 2 2 2 0
Reduce vomiting or fever 0 0 2 0 0
eas where caregiver preferences have not been significant-
ly affected by introduction campaigns or pilot projects.
The survey reported in this paper provides indications of 
how zinc is perceived and the attributes ascribed to it by 
caregivers in a rural, low–resource setting. About half of 
the surveyed women reported that their first intervention 
was some kind of home remedy, which could include 
homemade sugar/salt solution, foods, liquids, or herbs. In 
addition, antibiotics were given as the first or second inter-
vention by 46% of caregivers. For about one–half of the 
respondents, zinc was the third or fourth intervention in-
troduced. This sequence of treatments may reflect access 
and availability. The ingredients for home remedies are usu-
ally readily accessible and do not require a visit to a pro-
vider, making it an easy first choice. Antibiotics are more 
widely available than zinc through private–sector provid-
ers, drug vendors, and some shops. During the survey, zinc 
tablets were generally only available from public sector 
medical providers, clinics, or hospitals, which tend to be 
less accessible.
Despite the heavy use of antibiotics, many of the caregivers 
expressed overwhelmingly positive views of zinc treatment. 
Eighty–eight percent indicated that zinc was their preferred 
intervention, and only 5% preferred antibiotics.
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Of the 100 zinc users, 75 reported receiving ORS with the 
zinc. Of these, 59 actually used ORS during the course of 
the reference illness. Ideally, all 75 who received ORS 
should use it. However, the fact that some did not may re-
flect the lack of satisfaction with ORS as a treatment. Only 
6% indicated ORS was their preferred treatment choice.
Consistent with previous studies, our survey results indi-
cate that caregivers generally do not follow the recom-
mended 10–day course of zinc treatment, even when they 
know they should do so [8]. Caregivers typically stop treat-
ment once the child has returned to normal. Two–thirds of 
respondents reported giving zinc for fewer than 10 days. 
A large percentage indicated that they knew the correct 
regimen but for some reason chose to not follow it.
One–third indicated that they gave more than the recom-
mended daily dose of one 20 mg tablet per day. Typically, 
those who gave more gave two tablets in a day. There may 
be an attitude of “more is better.” In addition, given that 
most also gave antibiotics at some point, those who gave 
more than the daily dose of zinc may be mimicking a dos-
ing regimen more familiar to them, one more similar to the 
regimen of antibiotics. Programs that promote zinc as an 
alternative to antibiotics and that seek to position zinc as a 
medicine may want to monitor dosing behaviors for ap-
propriateness.
Recent studies suggest that 5–day course of zinc may be 
similar to a 10–day course in its effect on duration of ill-
ness [9]. Caregivers may be more likely to comply fully 
with the shorter course of treatment because it corresponds 
to the typical duration of illness and may reinforce satisfac-
tion and confidence of self–efficacy. In addition, a 5–tablet 
pack would undoubtedly make the product much less ex-
pensive. More research is needed to assess the efficacy of a 
shorter course.
Previous studies in controlled settings have indicated that 
the introduction of zinc has been associated with decreased 
use of antibiotics [10]. The results of this survey suggest 
that zinc treatment has a very strong appeal among care-
givers who have used it and is perceived as a highly effica-
cious product to stop diarrhea. More importantly, the vast 
majority indicated that they preferred zinc over any of the 
other options available to them, including antibiotics.
The small sample size and the quota sampling methodol-
ogy need to be considered when evaluating the survey re-
sults. The survey was not intended to be representative of 
all caregivers. Instead, it provided a snapshot of current 
perceptions. The quota sample was used to allow for sim-
plicity in locating and interviewing a population segment 
matching a specific criterion outside of a controlled re-
search environment–namely, caregivers who had used zinc 
to treat diarrhea in the past 6 months. Because of the 6–
month time frame, the survey is subject to recall bias. How-
ever, we believe the responses are predictive of future be-
haviors. In addition, knowing that the survey topic was 
about zinc may have biased the respondents towards a 
more positive perception of zinc. Finally, in most instances, 
respondents reported receiving the zinc treatment free of 
charge, which may have biased the stated preferences. We 
do not know how costs associated with obtaining the prod-
uct would influence perceptions and behaviors.
The survey results suggest that zinc has the potential to sup-
plant antibiotics as the diarrhea treatment of choice because 
of the strong perception that it stops diarrhea. However, 
treatment regimens for zinc remain unwieldy and unrealis-
tic, perhaps unnecessarily. In addition, the availability of 
zinc is limited primarily to public–sector providers. Greater 
access and availability, beyond the public clinic or hospital, 
may accelerate uptake and sustained use. More research is 
needed to determine the preferences and perceptions of zinc 
when cost is a factor.
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